expression. We also demonstrate that basal JNK activity does not affect either TGF-b-induced collagen gene expression or lattice contraction, whereas on the other hand, the blockage of motility initiated by JNK inhibition cannot be overcome by TGF-b. Together these results demonstrate discrete, yet significant and highly specific, regulation of fibroblast functions important for wound healing by basal JNK activity.
INTRODUCTION
Efficient cutaneous wound repair implies carefully orchestrated molecular events allowing fibroblasts to migrate to the wound site(s), contract the wound, and synthesize extracellular matrix (ECM) to restore skin integrity. Cellular signals underlying such events are not fully understood but it is well accepted that transforming growth factor-b (TGF-b), by means of its pleiotropic activities, plays a central role in orchestrating the various phases of wound healing (1) (2) (3) .
Extracellular stimuli elicit specific intracellular signals via activation of a family of socalled mitogen-activated protein kinases (MAP kinases), consisting of extracellular signalregulated kinases (ERK), p38 MAP kinases, and the c-Jun NH 2 -terminal kinases (4) (5) (6) . These MAP kinases phosphorylate transcription factors within the cell nucleus, thereby activating a number of cellular functions, including proliferation, apoptosis, differentiation, and regulation of gene expression. It has been reported that the ERK and p38 MAP kinases are activated in fibroblasts during collagen matrix contraction under isometric tension (7) , and that they cooperate in contraction-stimulated activation of the immediate early gene c-fos, although they are not required for lattice contraction per se (8) . In mechanically unloaded collagen lattices, on the other hand, ERK signaling is disrupted, a mechanism that may be responsible for the entry of fibroblast into a quiescent state after several days under these conditions (9) .
The JNK group of MAP kinases, also known as stress-activated kinases, are activated upon exposure of cells to cytokines, growth factors, and environmental stresses such as UV irradiation or heat shock (10) . Three distinct genes, jnk1, jnk2 and jnk3, have been identified to encode JNKs. The former two genes are ubiquitously expressed, whereas jnk3 is selectively expressed in the heart, testis and brain. Dual Thr and Tyr phosphorylation of JNK by the MAP kinase kinases, MKK4 and MKK7, results in JNK activation and nuclear translocation.
In the nucleus JNKs phosphorylate transcription factors such as c-Jun (11), a process that leads to maximal transcriptional activity of the latter (12) . Thus far, little is known about the role of JNK in the context of fibroblast ability to remodel collagen matrices, except that it was shown recently that JNK regulates the phenotypic modulation of lung fibroblasts into myofibroblasts induced by TGF-b (13), IL-4 and IL-13 (14) .
Recent data from our laboratory have indicated that basal JNK activity in fibroblasts maintains a limited, yet significant, pool of phosphorylated c-Jun protein (15) . In this report, using pharmacologic and genetic approaches aimed at interfering with basal JNK activity, we demonstrate a critical role for the latter in allowing fibroblast motility, whereas it inhibits their ability to contract free-floating collagen matrices, and does not modify the expression of fibrillar collagen genes, or their modulation by TGF-b. Details are provided herein. (16) in which targeted disruption of the jnk1 and jnk2 has been performed simultaneously, and junAA immortalized fibroblasts derived from mouse embryos carrying a mutant c-jun allele in which the JNK phospho-acceptor serines 63 and 73 are mutated to alanines (17) were a kind gift from Erwin F. Wagner (IMP, Vienna, Austria).
MATERIALS AND METHODS

Cell
Cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% heatinactivated fetal calf serum (FCS), 2 mM glutamine, and antibiotics (100 units/ml penicillin, 50 mg/ml streptomycin-G and 0.25 mg/ml Fungizone™). Human recombinant TGF-b1, purchased from R&D Systems Inc. (Minneapolis, MN), referred to as TGF-b throughout the text, was used at a concentration of 10 ng/ml. SP600125, a specific JNK inhibitor (18, 19) , was purchased from Calbiochem-Novabiochem GmbH (Schwalbach, Germany).
Collagen matrix contraction-Fibroblasts were harvested from monolayer culture with 0.25% trypsin and 1 mM EDTA, following which trypsin was neutralized with 10% FCS-containing medium. Collagen lattices in 60-mm dishes were prepared with 7 ml of a mixture containing 
RESULTS AND DISCUSSION
We first determined the JNK status under the experimental conditions used in the present study. To this aim, we first measured the respective levels of phospho-c-Jun, phospho-JNK1 and JNK1 in jnk cells. They also demonstrate that SP600125 at a concentration of 20 mM strongly reduces the basal phosphorylation levels of JNK and c-Jun in wt fibroblasts. These results were further confirmed in the mammalian one-hybrid system described in the "Materials and Methods" section, measuring the transcriptional status of Gal4BD-c-Jun under the various conditions described above (Fig. 1B) . We confirm the Western data as, (a) luciferase activity is dramatically lower in jnk -/-fibroblasts as compared to their wt counterparts, reflective of an absence of JNK activity in the former cell-type, and (b), SP600125 potently inhibits Gal4-lux activity in wt fibroblasts, consistent with its role as a JNK inhibitor (18, 19) acting on detectable basal kinase activity. These results are in agreement with our recent description that overexpression of a dominant-negative form of MKK4, the kinase directly upstream of JNK, reduces phospho-c-Jun-dependent transcription in unstimulated human dermal fibroblasts (15) .
Once the JNK status was clearly defined in our experiments, we examined the role its basal activity on fibroblast motility. Initially, we compared the motility of wild-type (wt), jnk The striking difference in cell motility between wt and jnk -/-immortalized fibroblasts raised the question whether such phenomenon may be specific for either the knockout or the immortalized phenotype. This led us to determine whether pharmacologic inhibition of JNK activity in either wt immortalized fibroblasts or human dermal fibroblasts would impair their motility in the same wound closure assay. For this purpose, we used SP600125, a specific JNK inhibitor (18, 19) , at a concentration of 20 mM, sufficient to inhibit basal JNK activity, as measured by either Western blotting for phospho-JNK or in a modified mammalian twohybrid system specific for phospho-c-Jun-driven transactivation (see Fig. 1 ). Under these conditions, wt fibroblasts treated with SP600125 were unable to close a mechanically-generated wound in a confluent cell layer (Fig. 3A, lower fibroblasts both exhibit impaired motility (Fig. 2 ) and increased contractile activity (Fig. 4) , as compared to their wt counterparts. Such identical behavior suggests that no other JNK substrate is able to replace the JunAA mutant in the context of either cell motility or capacity of fibroblasts to contract collagen gels. One plausible explanation would be that basal JunB expression (i.e. not induced by cytokines) in fibroblasts is very low, and is not sufficient to drive detectable JNKdependent transcriptional effects, whereas c-Jun is expressed at levels sufficient to transmit basal JNK activity. Another possibility may derive form the fact that JunB is a weaker transcriptional activator than c-Jun (27) (28) (29) . In the context of TNF-a-induced JunB neosynthesis, the latter relays, at least in part, some of the JNK signals when c-Jun expression, or activation by JNK, is blocked (15) .
Mechanistically, the small G protein Rac has been implicated in both cell motility and floating matrix contraction (30) . Furthermore, a parallel decrease in both fibroblast motility and their capacity to contract free-floating gels has been correlated to the aging process (31).
Specifically, poorly contractile fibroblasts derived from older tissue donors display lower motility than fibroblasts from younger donors, the latter also exhibiting a better capacity to contract free-floating collagen gels. It appears that the link between collagen gel contraction and cell motility is largely circumstantial, and no definitive mechanistic proof has been established thus far to link these two phenomena. Since the results presented above go against such scheme, we tried to establish another assay capable of addressing the issue of whether cell contact to collagen may modify fibroblast motility. For this purpose, we utilized another motility assay based on the Transwell™ system, able to measure the cell migratory potential through a nylon membrane pores in the absence or presence of a collagen coating (see 
CONCLUSIONS
Cell migration has been considered a key event responsible for collagen gel contraction by fibroblasts under mechanically unloaded conditions. The results presented in this report suggest that a correlation between the two phenomena is only coincidental, as cellular Specifically, we provide definitive evidence for a critical role for basal JNK activity in allowing fibroblasts to migrate whereas, at the mean time, it severely alters their capacity to contract collagen gels and does not affect fibrillar collagen gene expression.
Our data identify the basal activity of the JNK pathway as highly selective in controlling several fibroblast functions essential for tissue repair, namely cell migration, matrix contraction, and collagen biosynthesis. In vivo relevance to wound healing requires further investigations. were determined by Western analysis of whole cell lysates with specific antibodies. C, dermal
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